Related Experiment Video
Updated: Jun 26, 2026

Detection of SARS-CoV-2 Neutralizing Antibodies using High-Throughput Fluorescent Imaging of Pseudovirus Infection
Published on: June 5, 2021
Targeting host calcium channels and viroporins: a promising strategy for SARS-CoV-2 therapy
Mona Fani1,2, Maryam Moossavi3, Hasan Bakhshi1
1Vector-borne Diseases Research Center, North Khorasan University of Medical Sciences, Bojnurd, Iran.
Abstract:
Despite passing the pandemic phase of the COVID-19, researchers are still investigating various drugs. Previous evidence suggests that blocking the calcium channels may be a suitable treatment option. Ca2+ is required to enhance the fusion process of Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Also, some important inflammatory factors during SARS-CoV-2 infection are dependent on Ca2+ level. On the other hand, viroporins have emerged as attractive targets for antiviral therapy due to their essential role in viral replication and pathogenesis. By inhibiting the host calcium channels and viroporins, it is possible to limit the spread of infection. Therefore, calcium channel blockers (CCBs) and drugs targeting Viroporins can be considered an effective option in the fight against SARS-CoV-2.
Insights
Calcium channel blockers (CCBs) show promise for treating COVID-19 by inhibiting calcium channels essential for SARS-CoV-2 replication and inflammation. Targeting viroporins alongside CCBs may further limit viral spread.
Area of Science:
- Virology
- Pharmacology
- Immunology
Background:
- Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection involves complex host-pathogen interactions.
- Calcium ions (Ca2+) play a critical role in viral entry and inflammatory responses during SARS-CoV-2 infection.
- Viroporins are viral proteins crucial for replication and pathogenesis, making them potential therapeutic targets.
Purpose of the Study:
- To explore the potential of calcium channel blockers (CCBs) as a therapeutic strategy against SARS-CoV-2.
- To investigate the dual role of calcium channels in viral fusion and inflammatory pathways.
- To assess the combined therapeutic potential of CCBs and viroporin inhibitors for COVID-19 treatment.
Main Methods:
- Review of existing evidence on calcium channel function in SARS-CoV-2.
- Analysis of the role of Ca2+ in viral replication and host inflammatory responses.
- Evaluation of viroporins as antiviral targets.
Main Results:
- Ca2+ influx is necessary for the fusion process of SARS-CoV-2.
- Inflammatory factors associated with SARS-CoV-2 infection are modulated by Ca2+ levels.
- Inhibition of host calcium channels and viral viroporins can impede viral spread.
Conclusions:
- Calcium channel blockers (CCBs) represent a viable therapeutic option for COVID-19.
- Targeting both host calcium channels and viral viroporins offers a promising dual approach to antiviral therapy.
- Further research into CCBs and viroporin inhibitors is warranted for effective SARS-CoV-2 management.
Related Concept Videos
Human Virome
Coronavirus
Respiratory Syncytial Virus Disease
Inhibitors of Viral Protein Synthesis
Inhibitors Of Virion Release
Inhibitors of Virion Maturation and Assembly

